Prelude Capital Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$509K Sell
38,809
-11,186
-22% -$147K 0.05% 437
2025
Q1
$1.1M Buy
49,995
+16,831
+51% +$370K 0.08% 238
2024
Q4
$885K Buy
33,164
+3,871
+13% +$103K 0.06% 348
2024
Q3
$782K Buy
+29,293
New +$782K 0.05% 403